本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Castle Biosciences, Inc.

27.90
-1.6700-5.65%
成交量:25.67萬
成交額:728.16萬
市值:8.30億
市盈率:-33.48
高:29.36
開:28.74
低:27.75
收:29.57
52周最高:44.28
52周最低:14.59
股本:2,973.12萬
流通股本:2,511.27萬
量比:0.59
換手率:1.02%
股息:- -
股息率:- -
每股收益(TTM):-0.8334
每股收益(LYR):-0.8334
淨資產收益率:-5.21%
總資產收益率:-2.56%
市淨率:1.76
市盈率(LYR):-33.48

資料載入中...

2026/02/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/01/13

重要事件披露

Form 8-K - Current report
2026/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/11/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/03

重要事件披露

Form 8-K - Current report
2025/10/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities